Dr. Veloski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Moffitt Cancer Center
12902 Magnolia Drive
Tampa, FL 33612Phone+1 813-745-4673
Education & Training
- Temple University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2005 - 2007
- Temple University HospitalResidency, Internal Medicine, 1994 - 1997
- MCP-Hahnemann College of MedicineClass of 1994
Certifications & Licensure
- FL State Medical License 2018 - 2025
- PA State Medical License 1995 - 2021
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
Publications & Presentations
PubMed
- 94 citationsNivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancerJames Luke Godwin, Shuchie Jaggi, Imali Sirisena, Pankaj Sharda, Ajay D. Rao
Journal for Immunotherapy of Cancer. 2017-05-16 - 198 citationsEndocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management.Mario Sznol, Michael A. Postow, Marianne Davies, Anna C. Pavlick, Elizabeth R. Plimack
Cancer Treatment Reviews. 2017-07-01 - 69 citationsExtranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.M. Lango, Douglas B. Flieder, Rodrigo Arrangoiz, Colleen Veloski, Jian Q. Yu
Thyroid. 2013-09-09
Authored Content
- Endocrine-related adverse events associated with immune checkpointblockade and expert insights on their management7/1/2017
- Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.5/16/2017
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: